NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP

TIMP-2 和 MT1-MMP 的非蛋白水解相互作用

• 批准号: 8034818
• 负责人: Paolo Mignatti
• 金额: $ 34.12万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-03-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8034818
• 关键词: Address; Advocate; Binding; C-terminal; CD44 gene; Catalytic Domain; Cell Proliferation; Cell physiology; Cells; Chimera organism; Complex; Cytoplasmic Tail; Development; Extracellular Matrix; Favorable Clinical Outcome; Gelatinase A; Generations; Growth Factor Receptors; Health; Hemopexin; Immunodeficient Mouse; Immunologic Techniques; In Vitro; Integral Membrane Protein; Integrins; Knowledge; Lead; Matrix Metalloproteinases; Mediating; Mitogen-Activated Protein Kinases; Molecular; Mutation; N-terminal; Pathway interactions; Peptide Hydrolases; Phosphorylation; Physiological; Play; Process; Proteins; Proteolysis; Publishing; Role; Signal Pathway; Signal Transduction; Testing; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinases; Tumor Cell Invasion; Tumorigenicity; Up-Regulation; Xenograft Model; cell motility; design; extracellular; human MMP14 protein; in vivo; in vivo Model; inhibitor/antagonist; knockout gene; malignant breast neoplasm; migration; mutant; neoplastic cell; novel; outcome forecast; proMMP-2; tumor; tumor growth; tumor progression; tumor xenograft; tumorigenic

DESCRIPTION (provided by applicant): The invasion-promoting, tumorigenic membrane-type 1 matrix metalloproteinase (MT1-MMP), a transmembrane proteinase with extracellular catalytic, hemopexin (PEX) and hinge domains, and a short cytoplasmic tail, forms a stoichiometric complex with its physiological protein inhibitor, tissue inhibitor of metalloproteinases-2 (TIMP-2). It is well established that the proteolytic activity of MT1-MMP is required for tumor cell invasion and proliferation, and that TIMP-2 binds to the catalytic domain of MT1-MMP and blocks its proteolytic activity. Our extensive, recently published studies have shown that, in addition to extracellular proteolysis, MT1-MMP and TIMP-2 control cell proliferation and migration through a non-proteolytic mechanism. TIMP-2 binding to MT1-MMP induces activation of Extracellular signal-Regulated Kinase 1/2 (ERK1/2) by a mechanism independent of the MT1-MMP catalytic domain and the inhibitory domain of TIMP- 2. This effect involves TIMP-2 binding to the hemopexin and/or hinge domain and is mediated by the cytoplasmic tail of MT1-MMP. MT1-MMP-mediated activation of ERK1/2 upregulates cell migration and proliferation in vitro independently of extracellular matrix proteolysis. Consistent with this finding, proteolytically inactive MT1-MMP promotes tumor growth in vivo with an effect comparable to that of wild- type MT1-MMP. While these observations do not diminish the well-established importance of the proteolytic interactions involving TIMP-2 and MT1-MMP, our novel, unexpected findings strongly advocate a very important role for the proteolysis-independent signaling mechanism we identified. Because the ERK1/2 signaling pathway controls a variety of tumor cell functions including proliferation and migration, a detailed understanding of the molecular mechanism by which TIMP-2 - MT1-MMP interaction activates this signaling pathway can provide fundamental information for designing novel inhibitors to block tumor progression. Therefore, we propose to explore this novel signaling mechanism in detail by developing the following Specific Aims: 1) To identify the region(s) of the MT1-MMP PEX and/or hinge domains that mediate TIMP-2 binding and ERK1/2 activation, 2) To identify the region(s) of TIMP-2 required for binding to the PEX and/or hinge domain of MT1-MMP; 3) To characterize the mechanism of signal transduction from MT1-MMP to the Ras-ERK1/2 pathway; 4) To determine the functional role of TIMP-2 - MT1-MMP interaction in tumor growth in vivo. For this purpose we will use state-of-the-art molecular, cellular and immunological techniques and a tumor xenograft model in immunodeficient mice. The results of our study will lead to the understanding of the non-proteolytic role of MT1-MMP and TIMP-2 in tumor growth, and afford the development of novel inhibitors aimed to block MT1-MMP - TIMP-2 interaction and the generation of intracellular signaling that promotes tumor progression. PUBLIC HEALTH RELEVANCE: We found an unexpected, paradigm-shifting mechanism that controls tumor cell proliferation and migration, as well as tumor growth in an experimental in vivo model. Therefore, we propose to study in detail this novel mechanism and its functional role in tumor growth. The knowledge derived from our study will be of fundamental importance for designing novel pharmacological agents to block tumor progression.

描述（由申请人提供）：促侵袭、致瘤性膜1型基质金属蛋白酶（MT 1-MMP）是一种具有细胞外催化、血红素结合蛋白（PEX）和铰链结构域以及短胞质尾区的跨膜蛋白酶，与其生理蛋白抑制剂金属蛋白酶组织抑制剂-2（TIMP-2）形成化学计量复合物。已经确定，MT 1-MMP的蛋白水解活性是肿瘤细胞侵袭和增殖所必需的，并且TIMP-2结合到MT 1-MMP的催化结构域并阻断其蛋白水解活性。我们广泛的，最近发表的研究表明，除了细胞外的蛋白水解，MT 1-MMP和TIMP-2控制细胞增殖和迁移通过非蛋白水解机制。TIMP-2与MT 1-MMP的结合通过独立于MT 1-MMP催化结构域和TIMP- 2抑制结构域的机制诱导细胞外信号调节激酶1/2（ERK 1/2）的活化。这种作用涉及TIMP-2与血红素结合蛋白和/或铰链结构域的结合，并由MT 1-MMP的胞质尾区介导。MT 1-MMP介导的ERK 1/2激活在体外独立于细胞外基质蛋白水解上调细胞迁移和增殖。与该发现一致，蛋白水解无活性的MT 1-MMP促进体内肿瘤生长，其效果与野生型MT 1-MMP相当。虽然这些观察结果并没有减少涉及TIMP-2和MT 1-MMP的蛋白水解相互作用的公认的重要性，但我们的新的、意想不到的发现强烈主张我们鉴定的蛋白水解独立的信号传导机制具有非常重要的作用。由于ERK 1/2信号通路控制多种肿瘤细胞功能，包括增殖和迁移，详细了解TIMP-2 -MT 1-MMP相互作用激活该信号通路的分子机制可以为设计新型抑制剂以阻断肿瘤进展提供基础信息。因此，我们提出通过开发以下具体目标来详细探索这种新的信号传导机制：1）鉴定介导TIMP-2结合和ERK 1/2活化的MT 1-MMP PEX和/或铰链结构域的区域，2）鉴定TIMP-2与MT 1-MMP PEX和/或铰链结构域结合所需的区域; 3）探讨TIMP-2 -MT 1-MMP相互作用在肿瘤生长中的作用机制。为此，我们将使用最先进的分子，细胞和免疫学技术和肿瘤异种移植模型在免疫缺陷小鼠。我们的研究结果将有助于理解MT 1-MMP和TIMP-2在肿瘤生长中的非蛋白水解作用，并提供旨在阻断MT 1-MMP-TIMP-2相互作用和促进肿瘤进展的细胞内信号传导的产生的新型抑制剂的开发。公共卫生相关性：我们发现了一个意想不到的，范式转换机制，控制肿瘤细胞的增殖和迁移，以及在体内实验模型中的肿瘤生长。因此，我们建议详细研究这种新的机制及其在肿瘤生长中的功能作用。从我们的研究中获得的知识对于设计新的药物来阻断肿瘤进展具有根本的重要性。